Clinical radiology最新文献

{"title":"The perils of Double-J stent placement: What radiologists must know","authors":"B. Lucas ,&nbsp;C.B.H. Sulay ,&nbsp;G.S. Octavius","doi":"10.1016/j.crad.2025.106956","DOIUrl":"10.1016/j.crad.2025.106956","url":null,"abstract":"<div><div>The use of ureteral stents has seen a substantial rise in modern urological practice, serving as an indispensable tool in the management of urinary tract obstructions, stone disease, and postoperative drainage. However, their widespread application is accompanied by a high incidence of complications, each with potentially devastating consequences if left unrecognized. Encrustation and stone formation may result in obstruction, necessitating complex retrieval procedures. Stent migration can lead to severe discomfort, infection, and compromised renal function. Infection and pyelonephritis, if undetected, may progress to urosepsis, a life-threatening condition. Additionally, stent fracture and ureteral perforation can precipitate extensive morbidity, sometimes requiring surgical intervention. Given the critical nature of these complications, early detection through imaging is paramount. Radiologists play a pivotal role in diagnosing and characterizing these complications, ensuring timely management. By providing meticulous reporting of stent positioning, encrustation, migration, and associated pathologies, radiologists contribute to preventing severe adverse outcomes. A collaborative approach between urologists and radiologists is essential for optimizing patient care and mitigating the risks associated with prolonged stent placement.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"87 ","pages":"Article 106956"},"PeriodicalIF":2.1,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144230136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"RCR meetings","authors":"","doi":"10.1016/S0009-9260(25)00153-9","DOIUrl":"10.1016/S0009-9260(25)00153-9","url":null,"abstract":"","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"85 ","pages":"Article 106948"},"PeriodicalIF":2.1,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143948691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Paid MBP advert Paediatrics-CR-210x280_01","authors":"","doi":"10.1016/S0009-9260(25)00154-0","DOIUrl":"10.1016/S0009-9260(25)00154-0","url":null,"abstract":"","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"85 ","pages":"Article 106949"},"PeriodicalIF":2.1,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143948692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Imaging pancreatic cancer with [18F]F-AlF-NOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT): distribution patterns and therapeutic implications","authors":"C. Wang ,&nbsp;Z. Zhu ,&nbsp;L. Xu ,&nbsp;W. Li ,&nbsp;Y. Liu ,&nbsp;H. Wang ,&nbsp;Z. Ma ,&nbsp;R. Zhang ,&nbsp;X. Zhang ,&nbsp;J. Yue","doi":"10.1016/j.crad.2025.106954","DOIUrl":"10.1016/j.crad.2025.106954","url":null,"abstract":"<div><h3>AIM</h3><div>This study aimed to evaluate the diagnostic performance of [¹⁸F]F-AlF-NOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) in pancreatic cancer by comparing its uptake patterns with other tumour types and analysing intrapancreatic heterogeneity. The study also explored possible causes of physiological pancreatic uptake to aid in distinguishing non-malignant uptake from true pathological lesions and improve diagnostic accuracy.</div></div><div><h3>MATERIALS AND METHODS</h3><div>In this prospective study, 103 treatment-naïve cancer patients (36 pancreatic, 67 nonpancreatic) underwent [¹⁸F] AlF-NOTA-FAPI-04 PET/CT. Metabolic tumour volume (MTV), standardised uptake values (SUV), and total lesion Fibroblast Activation Protein (FAP) expression (TLF) were analysed. Hierarchical regression and independent t-tests were applied to assess correlations between imaging features and clinicopathological characteristics.</div></div><div><h3>RESULTS</h3><div>Pancreatic cancer exhibited significantly higher SUVmax (16.3 ± 4.4 vs 5.0 ± 4.3, <em>P&lt;0.001</em>), SUVmean (6.3 ± 2.3 vs 1.7 ± 1.2, <em>P&lt;0.001</em>), and TLF (321.5 ± 251.3 vs 89.4 ± 62.1, <em>P&lt;0.001</em>) compared to non-pancreatic tumors. Tumours in the pancreatic head/neck region demonstrated greater [68 G]G-FAPI-04 uptake than body/tail lesions (SUVmean: 7.7 ± 3.1 vs 6.3 ± 2.9, <em>P=0.016</em>). TLF correlated positively with tumour size and stage (F = 2.576, <em>P=0.027</em>). Mild to moderate pancreatic uptake was also observed in a subset of patients with hepatocellular carcinoma, partially correlating with elevated alkaline phosphatase (ALP) levels.</div></div><div><h3>CONCLUSION</h3><div>[¹⁸F]F-AlF-NOTA-FAPI-04 PET/CT shows high specificity for pancreatic ductal adenocarcinoma, particularly in head/neck tumours. Physiological or nonspecific pancreatic uptake in nonpancreatic malignancies warrants careful interpretation to avoid misdiagnosis.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"87 ","pages":"Article 106954"},"PeriodicalIF":2.1,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144270747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Growth patterns of true renal artery aneurysms in the current published literature","authors":"H. Briody ,&nbsp;E. Tong ,&nbsp;R.J. Lee ,&nbsp;G.R. Daly ,&nbsp;C. Brosnan ,&nbsp;K.P. Sheahan ,&nbsp;D.P. Mulholland ,&nbsp;M.J. Lee","doi":"10.1016/j.crad.2025.106957","DOIUrl":"10.1016/j.crad.2025.106957","url":null,"abstract":"<div><h3>AIM</h3><div>To describe the methods of surveying true renal artery aneurysms (RAAs) and identify the pattern of growth of RAA in the current literature.</div></div><div><h3>MATERIALS AND METHODS</h3><div>A comprehensive electronic database search was performed. The limits applied included full text and English language. The reference lists of included publications were manually searched for further relevant studies. Studies that surveyed RAA on imaging and calculated mean aneurysm growth rates per year were included.</div></div><div><h3>Results</h3><div>Literature review yielded six studies comprising 876 patients and approximately 988 aneurysms. Computed tomography (CT) was the most common imaging modality utilised for evaluation of RAA. Mean initial RAA diameter ranged from 1.21 to 1.6 cm. The combined cohort was followed radiologically for up to a maximum of 142 months and reports a zero percent rupture rate. Mean growth rates were consistently below 0.1 cm/y across the included studies (range: 0.017–0.086 cm/y).</div></div><div><h3>Conclusion</h3><div>The present study highlights a benign course of RAA. The current evidence yields a rupture rate of zero in a combined cohort of approximately 988 aneurysms followed for up to 11 years. Future guidelines should recognise this indolent course and consider rationalisation of RAA surveillance, particularly where initial aneurysm size is well below the threshold for treatment.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"86 ","pages":"Article 106957"},"PeriodicalIF":2.1,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144203098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tumour and adipose tissue uptake on 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) predict immunotherapy response in recurrent or metastatic nasopharyngeal carcinoma","authors":"J. Bao ,&nbsp;M. Xiong ,&nbsp;M. Zheng ,&nbsp;P. Huang ,&nbsp;X. Lin","doi":"10.1016/j.crad.2025.106959","DOIUrl":"10.1016/j.crad.2025.106959","url":null,"abstract":"<div><h3>AIM</h3><div>This study evaluated the prognostic value of ¹⁸F-Fluorodeoxyglucose (¹⁸F-FDG) uptake in tumour and adipose tissue in recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC) patients treated with immunotherapy.</div></div><div><h3>MATERIALS AND METHODS</h3><div>We retrospectively included 120 patients with R/M NPC treated with PD-1 inhibitors. Maximum standardised uptake value (SUV_max), metabolic tumour volume (MTV), and total lesion glycolysis (TLG) of all malignant lesions were recorded. Additionally, SUV_max and SUV_mean were measured for subcutaneous and visceral adipose tissue (SAT and VAT). The study classified patients who, within six months of immunotherapy, either experienced tumour progression, died, or changed treatment regimens as the nonclinical benefit (non-CB) group, and others as the CB group. The primary endpoints were progression-free survival (PFS) and overall survival (OS).</div></div><div><h3>RESULTS</h3><div>The CB group had significantly lower primary tumour MTV (PT-MTV) (median, 15.8 vs 48.1, <em>P</em>=0.006), PT-TLG (median, 88.7 vs 275.6, <em>P</em>=0.008) and SUV_max-VAT (median, 0.63 vs 0.77, <em>P</em>=0.047) than non-CB group. More T4 stages (71.4% vs. 41.3%) and lung metastases (42.9% vs 21.7%) were observed in the non-CB group compared to the CB group. Multivariate analysis indicated lung metastases (<em>P</em>=0.002, hazard ratio [HR] = 2.204, 95% confidence interval [CI]: 1.323–3.669) and higher primary tumour burden (<em>P</em>&lt;0.001, HR= 3.379, 95% CI: 1.768–6.460) as independent PFS predictors. Only higher primary tumour burden (<em>P</em>=0.027, HR=2.513, 95% CI: 1.108–5.698) was an independent OS predictor.</div></div><div><h3>CONCLUSION</h3><div>Our study indicates that higher primary tumour burden is associated with poor prognosis for NPC patients undergoing immunotherapy. SUV_max-VAT may be a promising predictor for immunotherapy response.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"87 ","pages":"Article 106959"},"PeriodicalIF":2.1,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144290875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Combining conventional magnetic resonance imaging (MRI) parameters with clinicopathologic data for differentiation of the three-tiered human epidermal growth factor receptor 2 (HER2) status in breast cancer","authors":"W. Liu ,&nbsp;C. Liu ,&nbsp;Y. Yang ,&nbsp;Y. Chen ,&nbsp;A. Muhetaier ,&nbsp;Z. Lin ,&nbsp;Z. Weng ,&nbsp;X. Wang ,&nbsp;P. Zhang ,&nbsp;J. Qin","doi":"10.1016/j.crad.2025.106955","DOIUrl":"10.1016/j.crad.2025.106955","url":null,"abstract":"<div><h3>AIM</h3><div>To assess the three-tiered human epidermal growth factor receptor 2 (HER2) classification of breast cancer (BC) patients based on conventional magnetic resonance imaging (MRI) parameters combined with clinicopathologic data.</div></div><div><h3>MATERIALS AND METHODS</h3><div>211 patients with invasive BC were retrospectively evaluated and divided into the HER2-zero, HER2-low, and HER2-positive BC groups. Patients underwent conventional dynamic contrast-enhanced breast MRI. Radiologists assessed clinicopathologic features and measured the apparent diffusion coefficient (ADC) and haemodynamic parameters to differentiate HER2-zero/-low (n=129) from HER2-positive (n=82) BC (task 1) and then HER2-zero (n=90) from HER2-low (n=57) BC (task 2). Patients were randomly assigned to the training and test sets at a ratio of 7:3. Univariate and multivariate logistic regression analyses were applied to select the most useful predictors. Receiver operating characteristic curve analysis was applied to evaluate the discriminative performance of the models.</div></div><div><h3>RESULTS</h3><div>The ADC and Ki-67 status were independently associated factors both for task 1 (OR: 41.22, 5.68) and task 2 (OR: 0.02, 0.29). The models established combining conventional MRI parameters with clinicopathologic data in the training set for task 1 and task 2 yielded an area under the curve (AUC) of 0.836 and 0.874, respectively, and demonstrated effective prediction in the test set, with the AUC of 0.845 for task 1 and an AUC of 0.805 for task 2, respectively.</div></div><div><h3>CONCLUSION</h3><div>Models combining conventional magnetic resonance imaging (MRI) parameters and clinicopathologic data could be valuable for differentiating BC HER2 expression, which may aid in selecting patients for HER2-targeted therapies in those without fluorescence in situ hybridisation results.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"86 ","pages":"Article 106955"},"PeriodicalIF":2.1,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144213151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epicardial adipose tissue associated with right cardiac chamber remodelling in patients with connective tissue disease evaluated by cardiac magnetic resonance: a cross-sectional study","authors":"Y. Tang ,&nbsp;Z. Pan ,&nbsp;J. Wen ,&nbsp;Z. Yang ,&nbsp;D. Tang ,&nbsp;Y. Luo ,&nbsp;C. Xiang ,&nbsp;L. Huang ,&nbsp;L. Xia","doi":"10.1016/j.crad.2025.106958","DOIUrl":"10.1016/j.crad.2025.106958","url":null,"abstract":"<div><h3>AIM</h3><div>The present study aimed to evaluate the relationship between epicardial adipose tissue (EAT) and right cardiac chamber remodelling in connective tissue disease (CTD) patients and to investigate the value of EAT in CTD-associated pulmonary hypertension (CTD-PH) patients.</div></div><div><h3>MATERIALS AND METHODS</h3><div>A total of 134 CTD patients and 64 age- and sex-matched controls who underwent cardiac magnetic resonance (CMR) examination were retrospectively enrolled. Systolic pulmonary arterial pressure (sPAP) measured by transthoracic echocardiography was recorded. Based on combined PH, patients were divided into two subgroups: CTD-PH and CTD-nonPH. Right heart strain parameters and EAT thickness and volume were measured using CVI42 (version 5.13.9, Circle Cardiovascular Imaging Inc., Calgary, Canada). Bootstrapping was used to analyse the mediating effect of right cardiac chamber remodelling between EAT volume index (EATVI) and sPAP in CTD patients. Logistic regression was used to explore the correlations between EAT and CTD-PH.</div></div><div><h3>RESULTS</h3><div>CTD-PH patients had significantly higher EATVI (43.82 [36.00, 61.27] ml/m² vs. 30.13 [24.06, 41.38] ml/m², <em>P</em>&lt;0.001) and more pronounced right cardiac chamber remodelling than controls. There was a mediating effect between EAT and pulmonary artery pressure in right ventricular myocardial mass index and right atrial conduit function. Multivariate logistic regression showed that EATVI remained an independent association for CTD-PH after adjustment for clinical factors.</div></div><div><h3>CONCLUSION</h3><div>EAT is significantly increased in CTD-PH patients with more pronounced right cardiac chamber remodelling, which may be one of the valuable parameters for risk stratification of CTD patients.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"87 ","pages":"Article 106958"},"PeriodicalIF":2.1,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144280477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Seven-year trends in computed tomography (CT) pulmonary angiography utilisation and predictors of positivity in a large emergency department","authors":"C.M. Hood ,&nbsp;C. Vo ,&nbsp;A.H. King ,&nbsp;S. Prasad ,&nbsp;M.D. Weintraub ,&nbsp;M.H. Lev ,&nbsp;A.D. Sodickson ,&nbsp;S. Saini ,&nbsp;M.S. Gee ,&nbsp;M.D. Succi","doi":"10.1016/j.crad.2025.106953","DOIUrl":"10.1016/j.crad.2025.106953","url":null,"abstract":"<div><h3>Aim</h3><div>To evaluate trends in computed tomography pulmonary angiography (CTPA) utilisation in an emergency department (ED) and identify factors associated with pulmonary embolism (PE) detection.</div></div><div><h3>Materials and Methods</h3><div>This retrospective study analysed CTPA exams from 2017–2023 at a quaternary urban ED. CTPA volumes were normalised to total ED visits and ED CTs. Logistic regression assessed predictors of positivity. CTPA-per-visit trends were modelled with negative-binomial regression.</div></div><div><h3>Results</h3><div>CTPA volume rose 49% from 2,467 in 2017 to 3,684 in 2023. Positivity rates remained stable (mean 9.1%, range 8.3%–10.6%, p=0.55). CTPA use peaked at 10.0% of ED CTs in 2021, declining to 8.3% by 2023 (p=0.30). CTPAs per 1,000 ED visits increased from ∼22 in 2017 to ∼40 in 2021, then fell to ∼31 in 2023 (p=0.75). Male patients had higher odds of a positive result (aOR 1.222, 95% CI: 1.115–1.339), as did Black (aOR 1.222, CI: 1.058–1.412) vs White patients. Asian patients had lower odds (aOR 0.647, CI 0.489–0.857). Overnight exams were less likely to yield PE (aOR 0.830, CI 0.730–0.945). Higher body mass index (BMI) (aOR 1.014, CI 1.006–1.022) and cancer history (aOR 1.185, CI 1.039–1.352) were also predictive. Ordering provider training level (MD/DO, NP, PA) did not affect diagnostic yield.</div></div><div><h3>Conclusion</h3><div>Over a seven-year period (2017–2023), annual CTPA volume and utilisation rate increased, but the positivity rate remained stable at ∼9%. Male sex, Black race, higher BMI, cancer history, and daytime imaging were associated with higher odds of PE. Provider training level was not associated with diagnostic yield.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"86 ","pages":"Article 106953"},"PeriodicalIF":2.1,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144203107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Elucidating the biological function of computed tomography (CT)-based radiomics biomarkers in serous ovarian cancer","authors":"M. Kishi ,&nbsp;D. Kawahara ,&nbsp;R. Nishioka ,&nbsp;I. Koh ,&nbsp;K. Tomono ,&nbsp;Y. Sato ,&nbsp;I. Nishibuchi ,&nbsp;Y. Murakami","doi":"10.1016/j.crad.2025.106952","DOIUrl":"10.1016/j.crad.2025.106952","url":null,"abstract":"<div><h3>AIM</h3><div>This study aims to elucidate the biological mechanisms in the tumour microenvironment as read from images by comprehensive Gene Set Enrichment Analysis (GSEA) based on radiomic features that predict survival. Furthermore, this study enables biological interpretation of survival prediction using radiomic features, which in turn allows for optimal treatment feedback to improve clinical outcomes.</div></div><div><h3>MATERIAL AND METHODS</h3><div>This retrospective study included serous ovarian cancer patients with pretreatment computed tomography (CT) images. Prognostic radiomic features were selected using least absolute shrinkage and selection operator (LASSO)-Cox regression and calculated as a Rad-score. Patients were classified into low- and high-risk groups (HRGs), and a survival prediction model was constructed. Model performance was evaluated with Kaplan–Meier curves, the log-rank test, and the C-index. GSEA identified gene sets associated with radiomic features linked to survival.</div></div><div><h3>RESULTS</h3><div>The Kaplan–Meier curve using the log-rank test (p&lt;0.01) and C-index values (0.768; 95% CI: 0.694–0.842) of the predictive models showed significant differences. GSEA was performed on the low- and HRGs, and the results identified a set of genes associated with cell proliferation, including the G2M checkpoint (p=0.006, FDR=0.138), mitotic spindle (p=0.006, FDR=0.156), and E2F targets (p=0.032, FDR=0.133).</div></div><div><h3>CONCLUSION</h3><div>This study revealed the biological functions underlying imaging features crucial for survival prediction and introduced an innovative approach to radiogenomics. This comprehensive approach promises to provide novel insights into the tumour microenvironment and potentially contribute to advancements in ovarian cancer treatment.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"86 ","pages":"Article 106952"},"PeriodicalIF":2.1,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144203099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}